|
Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia |
Floyd K, Hutubessy R, Kliiman K, Centis R, Khurieva N, Jakobowiak W, Danilovits M, Peremitin G, Keshavjee S, Migliori GB |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Floyd K, Hutubessy R, Kliiman K, Centis R, Khurieva N, Jakobowiak W, Danilovits M, Peremitin G, Keshavjee S, Migliori GB. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. European Respiratory Journal 2012; 40(1): 133-142 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Antitubercular Agents /economics /therapeutic use; Cohort Studies; Cost-Benefit Analysis; Estonia; Female; Health Care Costs; Humans; Male; Middle Aged; Quality-Adjusted Life Years; Russia; Treatment Outcome; Tuberculosis, Multidrug-Resistant /drug therapy /economics; World Health Organization; Young Adult AccessionNumber 22012027179 Date bibliographic record published 18/03/2013 |
|
|
|